Immunologix

Pharma

Human antibodies biotech firm Immunologix acquired by Intrexon

South Carolina biotechnology company Immunologix has been acquired by Virginia DNA technologies company Intrexon, which earlier this year raised $100 million in a series E round of fundraising. Charleston, South Carolina-based Immunologix has developed technology that transforms naive B lymphocytes into antibodies that can target a wide range of antigens including cancer, viruses, bacteria and […]